User:Elizabeth Schneider
From Proteopedia
| Line 4: | Line 4: | ||
| - | N-acetylglucosamine (GlcNAc) phosphotransferase is a cis-Golgi-localized enzyme that recognizes the specific protein sequence in newly synthesized lysosomal enzymes and transfers phosphorylated GlcNAc groups [ | + | N-acetylglucosamine (GlcNAc) phosphotransferase is a cis-Golgi-localized enzyme that recognizes the specific protein sequence in newly synthesized lysosomal enzymes and transfers phosphorylated GlcNAc groups [1]. Post-translational modifications occur via GlcNAc in the cytoplasm outside of the nucleus, including the protein glycosylation on serine and threonine residues [2]. |
| - | Any imbalance of phosphorylation can lead to diseases including cancer, diabetes, and neurodegenerative diseases. Management of phosphorylation and other modifications performed by GlcNAc can allow for better diagnoses and treatments of such diseases [ | + | Any imbalance of phosphorylation can lead to diseases including cancer, diabetes, and neurodegenerative diseases. Management of phosphorylation and other modifications performed by GlcNAc can allow for better diagnoses and treatments of such diseases [2]. |
| - | + | '''References''' | |
| - | Bioconjugate Chem., 2014, 25 (6), pp 1025–1030 | + | [1]. Bioconjugate Chem., 2014, 25 (6), pp 1025–1030 |
| - | + | [2]. Lodish, H. F., et al. Molecular cell biology, 8th ed.; W.H. Freeman-Macmillan Learning: New York, 2016. | |
| - | Lodish, H. F., et al. Molecular cell biology, 8th ed.; W.H. Freeman-Macmillan Learning: New York, 2016. | + | |
Revision as of 04:55, 6 April 2019
N-acetylglucosamine phosphotransferase
Elizabeth Schneider and Samantha Templeton; Students; Erskine College, Due West, SC, United States
N-acetylglucosamine (GlcNAc) phosphotransferase is a cis-Golgi-localized enzyme that recognizes the specific protein sequence in newly synthesized lysosomal enzymes and transfers phosphorylated GlcNAc groups [1]. Post-translational modifications occur via GlcNAc in the cytoplasm outside of the nucleus, including the protein glycosylation on serine and threonine residues [2].
Any imbalance of phosphorylation can lead to diseases including cancer, diabetes, and neurodegenerative diseases. Management of phosphorylation and other modifications performed by GlcNAc can allow for better diagnoses and treatments of such diseases [2].
References
[1]. Bioconjugate Chem., 2014, 25 (6), pp 1025–1030
[2]. Lodish, H. F., et al. Molecular cell biology, 8th ed.; W.H. Freeman-Macmillan Learning: New York, 2016.
